No particles
BPC-157 may help by: Supporting blood vessel formation (angiogenesis) to deliver oxygen and nutrients to healing tissue Supporting collagen production and connective tissue repair Helping regulate inflammatory signaling (so the body can shift from inflamed to healing) Supporting gut lining integrity and GI repair pathways TB-500 may help by: Supporting cell migration and tissue remodeling (important for recovery and regeneration) Supporting muscle recovery and range of motion Helping reduce stiffness and supporting mobility in overworked areas Supporting recovery when injuries involve multiple tissue layers (muscle + fascia + connective tissue) In simpler terms: BPC-157 focuses heavily on targeted tissue healing and inflammation control , while TB-500 is often used for broader recovery, mobility, and tissue regeneration support
They are not intended for human or animal use , including but not limited to consumption, injection, inhalation, topical application, diagnosis, treatment, cure, or prevention of any disease or medical condition
Common research characteristics: Compound type: Synthetic small molecule (research compound) Primary targets studied: ERR / ERR / ERR (non-selective agonist profile) Research focus: Nuclear receptor signaling, transcriptional regulation, mitochondrial-related gene programs Use setting: Controlled in vitro assays and non-clinical research models SLU-PP-332 peptide Scientific Research SLU-PP-332 is primarily used to study ERR-mediated signaling and the downstream transcriptional programs ERRs coordinate
